Overview

Efficacy Study of the Effect of Budesonide on Emphysema

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
To assess the effect of up to 4 years treatment with budesonide on progression of emphysema in patients with Chronic Obstructive Lung Disease.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide